https://respirerx.com/sample-page/2016-06-29T15:04:44-04:00https://respirerx.com/2024-05-29T09:54:21-04:00https://respirerx.com/wishlist/2016-06-29T15:04:44-04:00https://respirerx.com/company-overview/2021-09-22T16:41:29-04:00https://respirerx.com/company-management/2020-07-12T17:19:23-04:00https://respirerx.com/board-of-directors/2022-08-04T14:53:15-04:00https://respirerx.com/patents/2016-06-29T15:33:53-04:00https://respirerx.com/brain-controlled-breathing-disorders/2020-01-29T23:27:37-05:00https://respirerx.com/respiratory-depression/2020-01-29T23:29:25-05:00https://respirerx.com/sleep-apnea/2020-01-29T23:30:57-05:00https://respirerx.com/other-breathing-disorders/2016-06-29T15:04:44-04:00https://respirerx.com/additional-reading/2016-06-29T15:04:44-04:00https://respirerx.com/oral-dronabinol-for-obstructive-sleep-apnea/2016-06-29T15:04:44-04:00https://respirerx.com/cx1739/2016-06-29T15:33:18-04:00https://respirerx.com/cx1942-an-intravenous-drug-product-for-rd/2016-06-29T15:04:44-04:00https://respirerx.com/investor-contact/2021-10-11T16:09:21-04:00https://respirerx.com/faqs/2022-08-04T15:16:51-04:00https://respirerx.com/contacts/2016-06-29T15:04:44-04:00https://respirerx.com/product-pipeline/2021-09-02T22:33:32-04:00https://respirerx.com/news/2024-05-29T09:52:31-04:00https://respirerx.com/presentations/2023-04-24T13:04:27-04:00https://respirerx.com/contact/2021-10-11T16:08:59-04:00https://respirerx.com/development-programs-1/2017-07-11T23:22:20-04:00https://respirerx.com/cannabinoid-platform/2017-07-11T22:58:52-04:00https://respirerx.com/financial-summary/2017-07-12T00:16:27-04:00https://respirerx.com/social-media-guidelines/2018-03-14T15:44:43-04:00https://respirerx.com/cannabinoids-platform/2018-09-10T18:09:44-04:00https://respirerx.com/scientific-team-leaders/2022-08-04T14:57:59-04:00https://respirerx.com/neurotransmission/2021-09-22T20:09:18-04:00https://respirerx.com/resolutionrx-background/2021-09-02T21:33:54-04:00https://respirerx.com/pharmaceutical-cannabinoids/2022-08-04T15:20:45-04:00https://respirerx.com/obstructive-sleep-apnea/2022-08-04T15:21:54-04:00https://respirerx.com/dronabinol-for-the-treatment-of-obstructive-sleep-apnea/2021-10-11T15:49:03-04:00https://respirerx.com/regulatory-process/2021-09-02T21:44:07-04:00https://respirerx.com/ampakines-lead-compounds/2020-07-13T19:39:19-04:00https://respirerx.com/ampakines-adhd/2021-10-11T15:57:13-04:00https://respirerx.com/ampakines-spinal-cord-injury/2021-10-11T15:58:08-04:00https://respirerx.com/ampakines-autism-spectrum-disorder/2020-07-12T19:25:43-04:00https://respirerx.com/gabakines-background/2021-10-11T15:59:41-04:00https://respirerx.com/gabakines-epilepsy/2021-10-11T16:00:18-04:00https://respirerx.com/gabakines-pain/2021-10-11T16:00:57-04:00https://respirerx.com/coming-soon/2021-05-27T12:35:56-04:00https://respirerx.com/arnold-s-lippa-phd/2021-09-02T16:15:32-04:00https://respirerx.com/kathryn-macfarlane/2021-09-02T17:14:08-04:00https://respirerx.com/jeff-margolis/2021-09-21T13:54:46-04:00https://respirerx.com/richard-purcell/2021-09-02T20:35:15-04:00https://respirerx.com/david-dickason/2021-09-02T20:35:47-04:00https://respirerx.com/james-cook/2021-10-11T15:41:18-04:00https://respirerx.com/jeffrey-m-witkin/2021-10-11T15:42:07-04:00https://respirerx.com/rok-cerne/2021-09-03T15:42:06-04:00https://respirerx.com/marc-radin/2021-11-30T11:44:01-05:00https://respirerx.com/neuromodulatorsbackground/2021-09-21T17:45:57-04:00https://respirerx.com/ampakines-background/2021-10-11T15:54:55-04:00https://respirerx.com/11-07-2022-dr-arnold-lippa-presentation-at-meridian-drug-discovery-summit/2022-11-07T14:21:10-05:00https://respirerx.com/conflicts-of-interest-policy/2025-08-21T11:39:21-04:00